The aging population, high healthcare costs, limited medication resources, hospitals, doctors, as well as access to care are some examples of the challenges that every country must face. A global-level transition is necessary and will have to be achieved through the development of new technologies, research, and a reorganization of the system. Only close collaboration among governments, research institutions, healthcare industry companies, and healthcare facilities will enable us to meet these challenges. The patient’s journey must be at the core of a system that aims to be accessible, affordable, and equitable.
To improve the patient’s hospital journey, technolgies will play a pivotal role. They might provide solutions, such as AI for early disease detection, automation of certain tasks to address the shortage of personnel, and the practice of telemedicine to ensure healthcare access to everyone.
To further enhance partnerships, Swissnex in China is launching a new series called Future Hospitals on March 13. The event will explore emerging technologies and transformative solutions in the landscape of healthcare within the hospital setting and focus on the patient experience. This Swissnex initiative, structured as a series, aims to serve as a platform to bring together academic institutes, researchers, practitioners and companies from Switzerland and China to seek opportunities for collaboration between the two countries. From hospital design to patient well-being and clinical trials, the healthcare subject is broad, therefore the concept can be tailored to more specific topics based on the opportunities identified in collaborations with Swiss or Chinese partners.
Please note that this event is by invitation-only. If you are interested in attending, kindly provide us with a brief introduction to [email protected]
- 3:00pm – Host by Dr. Yan NIE, Deputy Director, Office of International Affairs, ShanghaiTech University
- 3:00pm – Philippe ROESLE, CEO & Consul, Swissnex in China
- 3:05pm – Dr. Jinglei WU, President, Shanghai Medical Association
Collaborative Opportunities between Research Hospitals and Industry
- 3:10pm – Moderator: Dr. Ying LEI, Deputy Director, Shanghai Institute for Advanced Immunochemical Studies (SIAIS); Research Director, Shanghai Clinical Research and Trial Center
- 3:10pm – Presentation by Dr. Chouwen ZHU, Director, Shanghai Clinical Research and Trial Center
- 3:20pm – Presentation by Prof. Christiane PAULI-MAGNUS, Co-head of the Department of Clinical Research at Basel University Hospital and the University of Basel
- 3:30pm – Presentation by Dr. Qun CHEN, PhD, CEO of Central Research Institute at UlH Group, Distinguished Adjunct Professor, BME, ShanghaiTech University
- 3:40pm – Presentation by Dr. Lianshan ZHANG, Board Member and Vice Director of Jiangsu Hengrui Pharmaceuticals
- 3:50pm – Panel Discussion
- 4:20pm – Coffee Break
Technology in Hospital Transformation
- 4:40pm – Moderator: Dr. Wuwei REN, Assistant Professor, School of Information Science and Technology, ShanghaiTech University; Swissnex Fellow
- 4:40pm – Presentation by Stefan SULZER, Managing Director & Dr. Minou Afzali, Head of Research, Swiss Centre for Design and Health
- 4:50pm – Presentation by Dr. Ze XIONG, Assistant Professor, School of Biomedical Engineering, ShanghaiTech University; Swissnex Fellow
- 5:00pm – Presentation by Dr. Frederick JOHNSON, Founder & CEO, SurgeonsLab
- 5:10pm – Panel Discussion
- 5:40pm – Dr. Yan NIE, Deputy Director, Office of International Affairs, ShanghaiTech University
Event start time
Dr. Chouwen ZHUPresident, Shanghai Clinical Research and Trial Center
Dr. Chouwen Zhu serves as the Founding Director of the Shanghai Clinical Research and Trial Center (as of the Center) since 2021 and a faculty member at the upcoming School of Medicine at ShanghaiTech University. With a career spanning over three decades, Dr. Zhu has established himself as an experienced gastroenterologist and clinical epidemiologist, and is actively involved in promoting collaborative research and evidence-based medicine. He holds the position of President of INCLEN-China (International Clinical Epidemiology Network – China) and ChinaCLEN (China Clinical Epidemiology Network). He also serves as a standing committee member of the Society of Evidence-based Medicine, the Chinese Medical Doctor Association, and an executive member of the Hospital Alliance Committee of the China Hospital Association.
Since 1992, when Dr. Zhu started his professional career in clinical medicine at Zhongshan Hospital, he demonstrated his outstanding professional capacity through the positions of resident, chief resident, attending physician and chief physician in the Department of Internal Medicine and Division of Gastroenterology and Hepatology. During his medical career period, he held various leadership positions, including Associate Director of Medical Service and Affairs at Zhongshan Hospital, responsible for quality surveillance, inter-departmental collaboration, and continuous education; Director of the University Foreign Affairs Office, responsible for all the international cooperation and exchanges; and Director of Medical Center Office, responsible for the coordination of medical college, public health school, nursing school and pharmacy school and several medical research institutes at Fudan University. Before joining the Center and ShanghaiTech University in 2021, Dr. Zhu was the Vice President at Zhongshan Hospital, affiliated with Fudan University, and President at Wusong District Central Hospital (member of Zhongshan Hospital Alliance). In addition, Dr. Zhu served as the Director of the China Medical Board Affairs Office at Fudan University, managing the execution of dozens of CMB projects for more than 10 years. Notably, Dr. Zhu played an instrumental role as the director of the Shanghai 5th batch of Medical Aid Team to Wuhan during the COVID-19 outbreak in 2020.
Besides his clinical and management work, Dr. Zhu kept teaching and graduate-supervising when he served as an associate professor at Shanghai Medical College, Fudan University for over 20 years.
Dr. Zhu obtained his MD from Peking Union Medical College in China in 1992, and he enhanced his clinical expertise through an exchange program at the UCSF School of Medicine in the United States. He also holds an MSc in Clinical Epidemiology/Health Development from Chulalongkorn University in Thailand and has enriched his knowledge as a senior visiting scholar at the CVS Digestive Center of Strong Memorial Hospital, University of Rochester.
Prof. Christiane PAULI-MAGNUSCo-head of the Department of Clinical Research at Basel University Hospital and the University of Basel
Christiane Pauli-Magnus has been Co-Head of the Department of Clinical Research at the University Hospital and the University of Basel since 2014 and President of the Swiss Clinical Trial Organization since 2017. Since 202, she has been a member of the Swiss Science Council, which advises the Swiss government on topics relating to the continuous improvement of education, research and innovation in Switzerland.
She studied medicine in Heidelberg and later in Würzburg, Germany, where she obtained her doctorate in 1996 after spending semesters abroad in France and Chile. After her clinical training, she spent 2000-2001 as a research fellow at the University of California in San Francisco, where she conducted research into the pharmacogenetics of drug transport processes in the intestine and at the blood-brain barrier. She then moved to the University Hospital Zurich, Switzerland, as a senior physician for clinical pharmacology and toxicology, where she qualified as a professor in 2004. In 2006, she took over the establishment and later the management of the Clinical Trial Unit at the University Hospital Basel, which she still heads today.
She is a specialist in general internal medicine and clinical pharmacology and Professor of Clinical Pharmacology and Toxicology at the University of Basel. In addition to her role as Head of Department, she has worked as a consultant in rheumatology.
Dr. Qun CHENPhD, CEO of Central Research Institute at UlH Group, Distinguished Adjunct Professor, BME, ShanghaiTech University
Qun Chen, Ph.D., CEO of the Central Research Institute (CRI) of UIH Group, Distinguished Professor of ShanghaiTech University, Adjunct Professor of Shanghai Jiao Tong University, graduated from Fudan University in 1982 (B.S.) and China Institute of Atomic Energy (CIAE) in 1985 (M.S.). After serving 2 years at CIAE (1985-1987) as a junior scientist, he went to the United States in 1987 for further education. Dr. Chen received his Ph.D. degree from the University of Kentucky in 1993 and continued his academic career in the field of medical imaging as a postdoctoral fellow at the University (1993-1995). After that, he served on the faculty of Harvard University (1996-2000), Northwestern University (2000-2003) and New York University (2003-2011). In January 2011, he joined a group of entrepreneurs to found the company United Imaging Healthcare (UIH) and has been with the company since. Dr. Chen is a well-recognized scientist in the field of MRI. The CRI team led by him has been committed to the exploration of cutting-edge medical imaging technology, including the research & development of state-of-the-art fast imaging methods, high-definition PET/MR systems, and novel algorithms for medical image applications.
Dr. Lianshan ZHANGBoard Member and Vice Director of Jiangsu Hengrui Pharmaceuticals
Dr. Lianshan Zhang holds the position of Board Member and Vice Director of Jiangsu Hengrui Pharmaceuticals. Hengrui is widely recognized as the domestic leader in pharmaceutical R&D innovation in China. In 2010, Dr. Zhang joined Hengrui and takes responsibility for the R&D strategy and management of dozens of NMEs across the globe. Prior to Hengrui, he was engaged in the discovery and development of peptide/protein therapeutics for the treatment of metabolic diseases in Eli Lilly and Marcadia Biotech. Dr. Zhang obtained his Ph.D. in Organic Chemistry at the University of Tubingen, and conducted his post-doctoral research at Vanderbilt University.
Dr. Ying LEIDeputy Director, Shanghai Institute for Advanced Immunochemical Studies (SIAIS); Research Director, Shanghai Clinical Research and Trial Center
Ying LEI received her B.S. degree in cell biology and genetics from Peking University in China, and her Ph.D. degree in cellular and molecular biology from Colorado State University in the US under the joint guidance of Professor Deborah Roess and Professor B. George Barisas. In 2005, she got her postdoctoral training in Dr. Helen Hobbs laboratory of the McDermott Center for Human Growth and Development, Southwestern Medical Center, University of Texas. After returning to China in 2008, she conducted drug discovery for neurodegenerative diseases at GlaxoSmithKline Shanghai R&D Center. Currently, she is the associate director of the Shanghai Institute for Advanced Immunochemical Studies (SIAIS), ShanghaiTech University, and the research director of Shanghai Clinical Research and Trial Center.
Stefan SULZERManaging Director, Swiss Centre for Design and Health
Stefan Sulzer is the Managing Director of the Swiss Center for Design and Health – SCDH. In 2018, the Bern University of Applied Sciences and the State of Bern entrusted Stefan Sulzer to help build a national technology competence center for design and health. Since its inception in 2019 as a public-private partnership, the SCDH’s focus lies on research-based projects, bringing together interdisciplinary academic research and the private sector in order to foster sustainable knowledge and technology transfer into the spheres of science, industry and society as a whole. Today, the SCDH employs 25 people with a wide range of skills and expertise. Together, they develop proven design solutions and standards that promote health. With his background in art and teaching at different universities and academies, Stefan aims to establish the SCDH as one of the pioneering organizations in the interface of design and health. As a leader he firmly believes that any organization’s success is contingent on its people. Fostering a diverse and inclusive culture that facilitates an environment where people can thrive and perform according to the best of their abilities is paramount for a lasting impact of the SCDH.
Dr. Minou AFZALIHead of Research, Swiss Centre for Design and Health
Dr. Minou Afzali is Head of Research at the Swiss Centre for Design and Health — Switzerland’s national Competence Centre at the interface between People, Healthcare, Design and Architecture. Prior to that, she was Deputy Head of the Institute of Design Research and Professor of Social Design at Bern Academy of Applied Sciences. Minou was also the coordinator of an interdisciplinary research group at the Bern University of Applied Sciences including experts from the fields of design, architecture, nursing, medical informatics and economics.
Minou holds a PhD in Social Anthropology from the University of Bern where she wrote her dissertation on the role of design in culture-specific nursing homes in Switzerland.
Dr. Ze XIONGAssistant Professor, School of Biomedical Engineering, ShanghaiTech University; Swissnex Fellow
Ze Xiong is an Assistant Professor and the Director of the Wireless and Smart Bioelectronics (WiSe) Lab in the School of Biomedical Engineering at ShanghaiTech University. He received his Ph.D. degree in Chemistry from The University of Hong Kong in 2017. After that, he worked as a Research Fellow at the National University of Singapore from 2018 to 2022. His research focuses on the development and application of wireless and smart bioelectronics to endow clinical and personalized healthcare procedures with digital intelligence. He has published over 40 peer-reviewed papers in journals such as Nature Biomedical Engineering, Nature Materials, Nature Nanotechnology, Science Advances, Nature Communications, Advanced Materials, etc., which have been highlighted by media outlets such as Reuters, Scientific American, AAAS, AIChE, People’s Daily, XinhuaNet, and ChinaDaily, etc. He holds 5 patents (2 PCT and 1 US patent) and contributed to 1 book chapter. He has served as a reviewer for impactful journals like Science Advances, Advanced Materials, and Advanced Science, etc. He was awarded the Shanghai Overseas High-Level Talent, 2023 Emerging Investigator of China (Outstanding Achievement Award), MINE 2023 Young Scientist Award, Swissnex Fellow, etc.
Dr. Frederick JOHNSONFounder and CEO, SurgeonsLab
Dr. Fredrick Johnson Joseph is the Founder and CEO of SurgeonsLab AG, a MedTech company based out of Switzerland University Hospital Bern. Fredrick pursued his doctorate, master’s, and bachelor’s in Medizintechnik from Switzerland, Germany, and India, respectively. He did his executive Business studies at Harvard Business and Medical Schools, Boston, USA. He specializes in the area of image-guided surgery. His earlier works include developing core technology, the Medical Science cycle, and Product-Market and translational medicine. He has nearly twelve years of working experience in medical devices, surgical intervention, imaging, and MedTech entrepreneurship.
He currently focuses on microsurgical procedure planning for brain surgery with his company. He aims to bring the device as a standard of care for pre-operative planning and training in Hospitals worldwide. He holds 4 international Patents and 16 International peer-reviewed papers. He won 6 global innovation prizes from the USA, Germany, Singapore, and Switzerland. He was awarded over 3.5 million US dollars of research and innovation grant funds only during the last years.
Dr. Wuwei RENAssistant Professor, School of Information Science and Technology, ShanghaiTech University; Swissnex Fellow
Dr. Wuwei Ren is a MedTech innovator. Now he is an Assistant Professor at ShanghaiTech University, and heads the Molecular Imaging and Biophotonics Laboratory focusing on next-generation optical imaging tools for early-stage diagnostics, drug development, and image-guided surgery. He earned his PhD degree from ETH Zurich in Switzerland. He also received BRIDGE Fellowship and VentureKick Award for his entrepreneurship.